Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma.
about
Trial Watch-Immunostimulation with cytokines in cancer therapyHigh incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survivalTargeted photo-chemo therapy of malignancy on the chest wall while cardiopulmonary avoidance based on Fe3O4@ZnO nanocomposites.Novelties in the management of B-cell malignancies: B-cell receptor signaling inhibitors and lenalidomide.B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy
P2860
Clinical outcomes of a novel combination of lenalidomide and rituximab followed by stem cell transplantation for relapsed/refractory aggressive B-cell non-hodgkin lymphoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@ast
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@en
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@nl
type
label
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@ast
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@en
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@nl
prefLabel
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@ast
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@en
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@nl
P2093
P2860
P356
P1433
P1476
Clinical outcomes of a novel c ...... e B-cell non-hodgkin lymphoma.
@en
P2093
Elyse Lopez
Huiqiang Huang
Jorge Romaguera
Liang Zhang
Maria Badillo
Michael Wang
Qingqing Cai
Shouhao Zhou
Tongyu Lin
P2860
P304
P356
10.18632/ONCOTARGET.2255
P407
P577
2014-09-01T00:00:00Z